Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-03

Clinical Trial Update: Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease [NA]

View source ↗

Summary

A pilot trial evaluating treating to target vitamin D in end-stage renal disease has been withdrawn; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of Nebraska | Conditions: Chronic Kidney Diseases | NA | Status: WITHDRAWN